Detalhe da pesquisa
1.
Rituximab, bendamustine and cytarabine (R-BAC) in patients with relapsed-refractory aggressive B-cell lymphoma.
Am J Hematol
; 93(12): E386-E389, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30184246
2.
Current Treatment Options and the Role of Functional Status Assessment in Classical Hodgkin Lymphoma in Older Adults: A Review.
Cancers (Basel)
; 15(5)2023 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36900306
3.
Salvage treatment with lenalidomide and dexamethasone in relapsed/refractory mantle cell lymphoma: clinical results and effects on microenvironment and neo-angiogenic biomarkers.
Haematologica
; 97(3): 416-22, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22058200
4.
Molecular characterization of post-transplant lymphoproliferative disorders of donor origin occurring in liver transplant recipients.
J Pathol
; 218(4): 478-86, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19391128
5.
Bendamustine and rituximab combination is safe and effective as salvage regimen in Waldenström macroglobulinemia.
Leuk Lymphoma
; 56(9): 2637-42, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25651423
6.
Panobinostat in combination with bortezomib and dexamethasone as induction therapy in patients with multiple myeloma, candidates for autologous transplant.
Leuk Lymphoma
; 56(6): 1901-2, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25347423
7.
Total serum tryptase: a predictive marker for KIT mutation in acute myeloid leukemia.
Leuk Res
; 33(9): 1282-4, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19406474
8.
Radiofrequency ablation of hepatic Hodgkin lymphoma.
Leuk Lymphoma
; 50(1): 141-4, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19152173